Skip to content
2000
Volume 20, Issue 2
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common form of cancer worldwide and the third most common cause of cancer-related death. In the beginning period, healing medicines, for example, careful resection, liver transplant and neighborhood removal, can improve the patient’s endurance. Be that as it may, the infection is identified in the cutting-edge stage; also, some accessible treatments are confined to palliative consideration and nearby treatment. Assessed the dietary benefit of some normal cell reinforcement specialists that help the capacity of the body coming about an improvement of the well-being and insurance from various ailments; our audit will give an updated status of the various parts of HCC the board through covering the viability and the advantageous impacts of various regular operators and their system of activity against HCC for the future treatment modalities. In this review, we talk about the ongoing advances identified with the reason (featuring the principle hazard factors), treatment, and result in hepatocellular carcinoma.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/1573394719666230626153347
2024-03-01
2025-05-23
Loading full text...

Full text loading...

/content/journals/cctr/10.2174/1573394719666230626153347
Loading

  • Article Type:
    Review Article
Keyword(s): antioxidant; HBV; HCV; hepatic cancer; Hepatocellular carcinoma; nano-antioxidant
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test